medirox ab-a shares (MROXA) Details

Medirox AB engages in the production and sale of instruments, diagnostic reagents, and quality control materials for visco elasticity and coagulation measurements worldwide. The company also develops and markets the ReoRox rheometers utilizing the Free Oscillating Rheometry technology. It provides various instruments, including ReoRox G2 to evaluate coagulation properties and to report viscosity and elasticity; ReoRox Jr, a channel analyzer for visco-elasticity; and D-dimer MRX143, an indicator of thrombotic events, such as deep venous thrombosis, pulmonary embolism, disseminated intravascular coagulation, and pregnancy complications. The company’s diagnostic reagents comprise D-dimer platform MRX series, PT Quick, PT Owren, Antithrombin liquid, Activated Partial Thromboplastine Time, and ReoTrap6. Its multi control products consist of OKP and NKP control plasmas for coagulation. Its products used in laboratory diagnostics, as well as for industry applications. The company operates as an OEM supplier to various international coagulation companies. Medirox AB was founded in 1998 and is based in Nyköping, Sweden.

medirox ab-a shares (MROXA) Top Compensated Officers